Delivery Order SPE2DB20D1004-SPE2DB25FNEYV

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,114.71, is for the delivery of Losartan Potassium 100 mg Tablets in 1,000 count quantities. The award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award, valued at $6,214.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,566,416,987 units of Losartan Potassium 100 mg tablets, a cardiovascular medication, with a completion date of November 7, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award, with a ceiling value of $2,153.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Losartan Potassium 100 mg tablets, with a period of performance through May 26, 2023. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,743.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,555,540,832 units of Losartan Potassium 100 mg tablets, with an ultimate completion date of November 30, 2021. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,564,840 units of Losartan Potassium 100 mg tablets. The contract has a ceiling value of $2,179.10 and a completion date of June 10, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,105.81, is a delivery order for 4,563,927,418 units of Losartan Potassium 100 mg tablets. The contract has an ultimate completion date of March 12, 2024 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,285.98 fixed-price delivery order is for the supply of 4,566,600 units of Losartan Potassium 100 mg tablets, a medication commonly used to treat high blood pressure and heart failure. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Losartan Potassium 100 mg tablets. The contract has a ceiling value of $3,473.52 and is a delivery order with a firm fixed price. The contract has an ultimate completion date of September 10, 2024. This award does not utilize any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,487.82 firm fixed-price delivery order is for the supply of 1,000 units of Losartan Potassium 100 mg tablets, a cardiovascular medication, with a performance period through May 2, 2024. The award is not set aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,249.22 firm fixed-price delivery order is for the supply of 4,566,693 units of Losartan Potassium 100 mg tablets. The contract has an ultimate completion date of December 12, 2024 and was awarded on December 11, 2024. This award appears to be part of a larger $999,999,999 Indefinite...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNEYV
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,580.30, is for the delivery of Losartan Potassium 100 mg tablets in 1000-count packages.

The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

This specific contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no mention of any major subcontractors in the provided information.

Generated 5/16/25, 11:57 AM